UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database

Journal of thoracic oncology, 2017-02, Vol.12 (2), p.302-313

2017

Volltextzugriff (PDF)

Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use

Annals of surgical oncology, 2021-10, Vol.28 (11), p.6083-6096

2021

Volltextzugriff (PDF)

Corrigendum re “Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?” [Eur Urol Open Sci 2020;22:9–16]

European urology open science (Online), 2022-10, Vol.44, p.52-53

2022

Volltextzugriff (PDF)

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?

European urology open science (Online), 2020-12, Vol.22, p.9-16

2020

Volltextzugriff (PDF)

Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [ 18 F]DCFPyL PET/CT in prostate cancer men

Scientific reports, 2023-05, Vol.13 (1), p.8321-8321, Article 8321

2023

Volltextzugriff (PDF)

Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer

World journal of urology, 2022-05, Vol.40 (5), p.1143-1150

2022

Volltextzugriff (PDF)

Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)

BMC urology, 2024-07, Vol.24 (1), p.1-9, Article 151

2024

Volltextzugriff (PDF)

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

BMC cancer, 2023-09, Vol.23 (1), p.1-923, Article 923

2023

Volltextzugriff (PDF)

MRI-LINAC: A transformative technology in radiation oncology

Frontiers in oncology, 2023-01, Vol.13, p.1117874-1117874

2023

Volltextzugriff (PDF)

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)

BMC cancer, 2023-08, Vol.23 (1), p.1-781, Article 781

2023

Volltextzugriff (PDF)

68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study

Translational oncology, 2022-01, Vol.15 (1), p.101242, Article 101242

2022

Volltextzugriff (PDF)

Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation

Radiation oncology (London, England), 2023-11, Vol.18 (1), p.188-188, Article 188

2023

Volltextzugriff (PDF)

Reasons for Discordance between 68Ga-PSMA-PET and Magnetic Resonance Imaging in Men with Metastatic Prostate Cancer

Cancers, 2024-05, Vol.16 (11), p.2056

2024

Volltextzugriff (PDF)

166 Radiation Therapy and IRreversible Electroporation (RTIRE) for Intermediate Risk Prostate Cancer

Journal of clinical and translational science, 2024-04, Vol.8 (s1), p.50-50

2024

Volltextzugriff (PDF)

MR-LINAC, a New Partner in Radiation Oncology: Current Landscape

Cancers, 2024-01, Vol.16 (2), p.270

2024

Volltextzugriff (PDF)

Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology

Frontiers in oncology, 2022-09, Vol.12, p.962897

2022

Volltextzugriff (PDF)

Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy

Advances in radiation oncology, 2022-07, Vol.7 (4), p.100904-100904, Article 100904

2022

Volltextzugriff (PDF)

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments

Clinical and translational radiation oncology, 2023-01, Vol.38, p.161-168

2023

Volltextzugriff (PDF)

Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation

Clinical and translational radiation oncology, 2021-11, Vol.31, p.21-27

2021

Volltextzugriff (PDF)

Smart materials types, properties and applications: A review

Materials today : proceedings, 2020, Vol.28, p.1302-1306

2020

Volltextzugriff (PDF)

Point: Rectal Spacer Use is Recommended for All Prostate Cancer Radiation Therapy Fractionation Regimens

International journal of radiation oncology, biology, physics, 2024-09, Vol.120 (1), p.33-35

2024

Volltextzugriff (PDF)

PD20-08 TRENDS IN PROSTATE CANCER SPECIFIC MORTALITY BY RACE OVER TIME: A SEER ANALYSIS

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?

International journal of radiation oncology, biology, physics, 2021-09, Vol.111 (1), p.110-112

2021

Volltextzugriff (PDF)

Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?

International journal of radiation oncology, biology, physics, 2020-06, Vol.107 (2), p.297-298

2020

Volltextzugriff (PDF)

MP38-17 PROSTATE CANCER GRADE MIGRATION AND FACILITY-LEVEL TREATMENT TRENDS FOR LOW GRADE DISEASE

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(95)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(38)
Oncology
(28)
Prostate Cancer
(20)
Humans
(18)
Male
(16)
Radiation Therapy
(13)
Radiology, Nuclear Medicine & Medical Imaging
(12)
Magnetic Resonance Imaging
(11)
Cancer Therapies
(9)
Patients
(8)
Radiotherapy
(8)
Care And Treatment
(7)
Urology & Nephrology
(7)
Prostate
(5)
Prostate - Pathology
(5)
Prostatectomy
(5)
Prostatic Neoplasms - Diagnostic Imaging
(5)
Prostatic Neoplasms - Radiotherapy
(5)
Radiation
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database

Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use

Corrigendum re “Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?” [Eur Urol Open Sci 2020;22:9–16]

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?

Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [ 18 F]DCFPyL PET/CT in prostate cancer men

Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer

Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

MRI-LINAC: A transformative technology in radiation oncology

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)

68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study

Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation

Reasons for Discordance between 68Ga-PSMA-PET and Magnetic Resonance Imaging in Men with Metastatic Prostate Cancer

166 Radiation Therapy and IRreversible Electroporation (RTIRE) for Intermediate Risk Prostate Cancer

MR-LINAC, a New Partner in Radiation Oncology: Current Landscape

Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology

Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments

Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation

Smart materials types, properties and applications: A review

Point: Rectal Spacer Use is Recommended for All Prostate Cancer Radiation Therapy Fractionation Regimens

PD20-08 TRENDS IN PROSTATE CANCER SPECIFIC MORTALITY BY RACE OVER TIME: A SEER ANALYSIS

Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?

Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?

MP38-17 PROSTATE CANCER GRADE MIGRATION AND FACILITY-LEVEL TREATMENT TRENDS FOR LOW GRADE DISEASE

Aktive Filter

Suchergebnisse filtern